J. Stern & Co. LLP
- SEC CIK
- 0002011335
- Latest filing
- Aug 14, 2026
ABT holding history
Abbott Laboratories in every 13F filed by J. Stern & Co. LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 311,229
- Value
- $28.2M
- % of portfolio
- 2.7%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 311,229 | $28.2M | 2.7% | −4,729−1.5% | Reduced | Holders |
| Q1 2026 | 315,958 | $32.4M | 3.1% | −39,003,051−99.2% | Reduced | Holders |
| Q4 2025 | 39,319,009 | $39.3M | 3.4% | +39,005,451+12,439.6% | Added | Holders |
| Q3 2025 | 313,558 | $42.0M | 3.2% | −38,149−10.8% | Reduced | Holders |
| Q2 2025 | 351,707 | $46.8M | 4.0% | +10,921+3.2% | Added | Holders |
| Q1 2025 | 340,786 | $45.2M | 4.3% | +25,353+8.0% | Added | Holders |
| Q4 2024 | 315,433 | $35.7M | 3.4% | +16,300+5.4% | Added | Holders |
| Q3 2024 | 299,133 | $34.1M | 3.6% | +3,977+1.3% | Added | Holders |
| Q2 2024 | 295,156 | $30.7M | 3.7% | +10,316+3.6% | Added | Holders |
| Q1 2024 | 284,840 | $32.4M | 4.1% | +72,913+34.4% | Added | Holders |
| Q4 2023 | 211,927 | $24.0M | 4.4% | – | No prior filing | Holders |